great to hear FXm re JPR.Bravo !!!The noteholders who hold plenty at 3c average are holding out for their 20c plus on that recent independant CPR valuation that was prepared. TO coming ! Took 3 months to compile that report !!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
